Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos de Reumatologia | EligiMed
Ensayos clinicos
432 ensayos encontrados
Completado
ClinicalTrials.gov
A Multi-national, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab Actemra
OBSERVATIONAL
Inicio: 1 de feb de 2012
ID: NCT01562327
Desconocido
ClinicalTrials.gov
Lupus Flares and Histological Renal Activity at the End of the Treatment
OBSERVATIONAL
Inicio: 1 de ene de 2014
ID: NCT02313974
Completado
Fase 3
ClinicalTrials.gov
A Long-Term Extension Study to Demonstrate Safety of Tildrakizumab in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.
INTERVENTIONAL
Inicio: 11 de jul de 2018
ID: NCT03552276
Completado
Fase 4
ClinicalTrials.gov
A 52-Week Multicenter, Randomized, Open-Label, Parallel- Group Study Evaluating the Efficacy and Safety of Ixekizumab Versus Adalimumab in Patients With Psoriatic Arthritis Who Are Biologic Disease-Modifying Anti-Rheumatic Drug Naive
INTERVENTIONAL
Inicio: 24 de ago de 2017
ID: NCT03151551
Completado
Fase 2
ClinicalTrials.gov
A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects With Active Proliferative Lupus Nephritis
INTERVENTIONAL
Inicio: 4 de nov de 2015
ID: NCT02547922
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Active Controlled, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response and Maintaining Remission in Subjects With Lupus Nephritis.
INTERVENTIONAL
Inicio: 1 de jul de 2005
ID: NCT00377637
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01232569
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Concomitant Methotrexate Therapy
INTERVENTIONAL
Inicio: 1 de ago de 2012
ID: NCT01645280
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-experienced Participants With Active Psoriatic Arthritis
INTERVENTIONAL
Inicio: 9 de ene de 2025
ID: NCT06807424
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate Therapy (FLEX M)
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01198002
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA)
INTERVENTIONAL
Inicio: 1 de jun de 2011
ID: NCT01215942
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Multi-center, Open-Label Study to Evaluate Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
INTERVENTIONAL
Inicio: 30 de ago de 2013
ID: NCT01844518
Anterior
1
...
21
22
Filtros